In gene therapy, vector–chromatin interaction and its consequences have become more unpredictable, but vector-induced leukemogenesis remains an predictable factor in gene therapy due to its multifactorial nature.
In gene therapy, vector–chromatin interaction and its consequences have become more unpredictable, but vector-induced leukemogenesis remains an predictable factor in gene therapy due to its multifactorial nature.
1